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ABSTRACT A small set of concanavalin A (Con A)-bind-
ing glycoproteins was isolated from the surface membrane of
cloned cytotoxic T lymphocytes (CTL) and partly identified
using monoclonal antibodies. The binding of Con A by these
glycoproteins on the CTL surface results in the secretion of y-
interferon and in blocking the effector functions of the cells
namely, antigen-specific and lectin-dependent cytotoxicity.
The Con A is evidently bound tightly to some surface struc-
tures ("Con A-receptors") that are required for the activation
and cytotoxic activity of CTL. To isolate and identify these
receptors, antibodies to Con A were used. After Con A was
allowed to bind to radiolabeled cloned CTL (labeled with '2 I
or [35S]methionine or 3H-labeled amino acids), the cells were
washed thoroughly, lysed in detergents and anti-Con A anti-
bodies were added to bind to the Con A-receptor complexes.
The resulting aggregates were adsorbed with protein A-bear-
ing Staphylococci and the receptors were then specifically re-
leased from the pelleted bacteria by a-methyl-D-mannoside
and analyzed by polyacrylamide gel electrophoresis under re-
ducing conditions. Eight to nine labeled components were seen
by autoradiography and with the aid of monoclonal antibodies
to known T-cell surface molecules, four were identified as
T200, lymphocyte function-associated antigen (LFA)-1, a- and
.8-chains, and (on some clones) Lyt-2. Other components with
Mr = 160,000, 120,000, 46,000, 42,000, and 23,000 have not
been identified. The procedures described here may have gen-
eral application in the studies of the functional properties of
other cell surface molecules.
Cytotoxic T lymphocytes (CTL) are distinguished by their
ability to lyse target cells by reactions that depend on specif-
ic recognition of target-cell surface antigens. The antigens
are usually either (i) foreign class I molecules encoded by the
major histocompatibility complex (H2-K, H2-L, H2-D in the
mouse) or (ii) any of a great variety of other target-cell sur-
face antigens that are recognized in conjunction with class I
molecules on the same target cells (1-3). The usual way of
identifying the CTL surface molecules that might be in-
volved in recognition, adhesion to, or lysis of target cells has
been through inhibition of cytotoxic activity by antibodies to
CTL surface antigens (4-7). Because immunogenicity is not
always predictable and because the critical molecules on
CTL are likely to be glycoproteins, we previously explored
the use of lectins, in place of antibodies, as selective inhibi-
tors of CTL activity (8). Several lectins were tested and one,
concanavalin A (Con A), turned out to be promising: at low,
nonagglutinating concentrations, Con A bound to CTL and
blocked their ability to lyse their specific target cells; the
effect was carbohydrate specific and could be completely
reversed by stripping bound Con A from the CTL with a-
methylmannoside (8, 9). It was not clear, however, whether
the surface structures that are required for CTL activity ac-
tually bind Con A, or whether they are unable to bind it but
are simply near neighbors of molecules that do. Some of the
studies described here provide evidence that Con A-binding
structures (hereafter called Con A receptors) on CTL are
themselves involved in reactions with target cells. We have,
accordingly, developed procedures based on the use of Con
A and anti-Con A antibodies to isolate and characterize
these receptors.
MATERIALS AND METHODS
CTL and Assay for Cytotoxicity. Cloned CTL lines (G4,
B10, 1D, 2C) were derived and maintained as described (10,
11). H-2-restricted CTL clone cr 15 (12) was provided by M.
Bevan.
Cytotoxic activity was measured in a standard 4-hr 51Cr-
release assay (13), using 51Cr-labeled P815 cells (H-2d) as
specific targets.
Antibodies. Monoclonal antibodies (mAb) to T-cell surface
antigens were used as unfractionated culture supernatants
from hybridoma cell cultures. Hybridoma culture superna-
tants containing rat mAb to T200 (M 1/9.3, IgG) and rat mAb
to lymphocyte function-associated antigen (LFA)-1 (M 7/14,
IgG) were provided by T. Springer (6). Culture supernatants
containing another rat mAb to T200 (13/2.3 IgG) was fur-
nished by I. Trowbridge (14). Hybridoma cells 3.155 were a
gift from F. Fitch; these cells produce a rat mAb (IgM) to
Lyt-2 (15).
Conventional mouse anti-Lyt-2 alloantiserum was pre-
pared in this laboratory (16). Rabbit antiserum to Con A and
purified rabbit anti-Con A antibodies were obtained from
Vector Laboratories (Burlington, CA) or were prepared by
immunizing rabbits with Con A and affinity purifying the
anti-Con A antibodies on a Con A-Sepharose column in the
presence of a-methylmannoside.
Concanavalin A. This lectin and fluorescein isothiocyanate
(FITC)-labeled and rhodamine isothiocyanate (RITC)-la-
beled Con A was purchased from Vector Laboratories.
Fluorescence-Activated Cell Sorter Analyses. Cells with ad-
sorbed FITC-labeled antibodies or RITC-labeled Con A
were analyzed in a flow cytometer (Cytofluorograph System
GOH, Ortho Diagnostic), usually with 30,000 cells per run.
For FITC-labeled and RITC-labeled ligands, the excitation
source (argon ion laser) was set at 500 mW of output at 488
nm and 514 nm, respectively; the detectors were set at 520-
540 nm (for FITC) and >610 nm (for RITC). For indirect
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immunofluorescence, FITC-labeled rabbit anti-mouse Ig and
FITC-labeled goat anti-rat Ig (both from Cappel Labora-
tories, Cochranville, PA) were used as second antibodies.
Radiolabeling of Lymphocytes. Cultured cells were centri-
fuged through Ficoll-Hypaque on a discontinuous 17.5%-
35% bovine serum albumin gradient, and the recovered cells
(>95% viable) were iodinated with 125I and lactoperoxidase
(13). To label cell surface components metabolically, cloned
CTL (G4 and 1D) were incubated with [35S]methionine or a
mixture of 3H-labeled amino acids (New England Nuclear) in
amino acid-depleted RPMI 1640 ("Select Amino Acid Kit",
GIBCO), containing 10% dialyzed fetal calf serum. After 14-
20 hr at 370C, dead cells were removed by centrifugation
through Ficoll-Paque.
Isolation of Con A Receptors. Briefly, the procedures used
to isolate these structures involved incubating the radiola-
beled cells with Con A, washing away unbound Con A, lys-
ing the resulting cells, and specifically immunoprecipitating
the solubilized Con A-receptor complexes with anti-Con A
antibodies and protein A-bearing Staphylococcus aureus
(Cowan I) ("Staph A").
The CTL were first surface-labeled with 1251 or metaboli-
cally labeled with [35S]methionine, and then the washed cells
were incubated for 45 min at 370C at 1 x 106 cells per ml in
serum-free RPMI 1640 containing 2 mg of bovine serum
albumin per ml (0.2% albumin/RPMI 1640) and 2.5 ,ug of
Con A per ml (9). After removing unbound Con A by three
cycles of centrifugation in ice-cold 0.2% albumin/RPMI
1640, the resulting cells (called Con A-CTL) were lysed by
suspending them at 2 x 107 cells per ml in Con A extraction
buffer: 0.5% Nonidet P-40/150 mM NaCl/50 mM Tris HCl,
pH 7.5/2 mM phenylmethylsulfonyl fluoride/1 mM CaCl2/1
mM MgCl2/0.01% albumin/0.02% NaN3. The suspension
was mixed vigorously for 5-10 sec in a Vortex mixer and
then incubated at 0°C for 15 min with intermittent mixing.
Nuclei and debris were removed by centrifugation (Eppen-
dorf, Model 3200) in the cold at 8000 x g for 2-3 min. The
supernatants (Con A-CTL extracts) were depleted of non-
specifically binding components by twice incubating them
with normal mouse or rabbit antiserum (25 /1 of antiserum
per ml of extract for each adsorption) and formalin-fixed
Staph A. To bind the Con A-receptor complexes specifical-
ly, affinity-purified rabbit antibodies to Con A (10 ug in 20
,1.) were added, and after incubating the mixture for 30 min
on ice, 100 ul of a 20% suspension of Staph A in Con A
extraction buffer was added. After 30 min at 4°C with contin-
uous mixing, the bacterial pellets with adherent complexes
were centrifuged (8000 x g, 15 sec), washed 3 times in Con A
extraction buffer, and the receptors were eluted by either (i)
three successive extractions with a-methylmannoside (150
,u4 containing 200mM a-methylmannoside in Con A extrac-
tion buffer), each for 15 min at 37°C, or (ii) one extraction
with the sample buffer used for electrophoresis (3-5 min in a
boiling water bath). Approximately 50-65% of the radiola-
beled components adsorbed by the pellets were extracted
with a-methylmannoside and 80-90% were extracted with
NaDodSO4/PAGE sample buffer (17).
NaDodSO4/PAGE and Autoradiography. Material eluted
from the Staph A pellets were analyzed by polyacrylamide
slab gel electrophoresis in 0.1% NaDodSO4, under reducing
conditions, using a discontinuous pH gradient (18). Autora-
diographs were prepared from dried gels with XAR-5 x-ray
film (Kodak).
Characterization of Con A Receptors. Radiolabeled Con A
receptors, eluted from Staph A-bound immune complexes
with a-methylmannoside, were characterized by sequential
immunoprecipitations with various mAb, using appropriate
anti-Ig antibodies to facilitate binding to Staph A. The im-
munoprecipitated receptors were analyzed by NaDodSO4/
PAGE.
(y-IFN) Production. CTL (clone 2C) 2 x 106 cells were
incubated with 2.5 ug of Con A in 1.0 ml ofRPMI 1640/0.1%
albumin for 45 min at 370C. After washing the cells 4 times
the Con A-CTL were incubated for 20 hr in IFN-free medi-
um. y-IFN activity was determined in the harvested super-
natant as described (19). To obtain T-cell growth factor free
of y-IFN, culture supernatants from Con A-stimulated
AOFC cells were used (20).
Other Methods and Reagents. Previously described meth-
ods were used to generate conventional (polyclonal) second-
ary BALB.B anti-BALB/c CTL (13), to prepare 125I-labeled
Con A (8), and to remove bound Con A from Con A-CTL
(8).
RESULTS
It was found previously that when Con A-CTL are incubat-
ed at 370C they gradually lose their ability to recover cyto-
toxic activity after surface-bound Con A is eluted with a-
methylmannoside (8). This change did not occur, or was
very much slower, when the cells were incubated at 0C. At
the low temperature, full recovery of cytotoxic activity, after
the removal of Con A with a-methylmannoside, persisted for
at least 8 hr. The difference implies that there is a tempera-
ture-dependent Con A-induced loss of some of the surface
receptors for Con A (modulation). Using FITC-labeled Con
A we have observed that surface "patching" of Con A on the
surface of cloned CTL does indeed occur at 370C but not at
OC.
Con A-Induced Modulation. To analyze these effects in
greater detail, Con A-CTL that had been incubated for 4 hr
at 370C were compared with control Con A-CTL (incubated
for the same time at 00C) in regard to recovery of their cyto-
toxic activity after removing Con A from the cell surface. In
parallel, the same cell populations were subjected to fluores-
cence-activated cell sorter analysis using either RITC-la-
beled Con A or a rat mAb to one of the structures identified
below as a Con A receptor (T200) plus FITC-labeled goat
antibodies to rat Ig.
A representative result (Fig. lA) confirms the previous
finding that after 4 hr at0OC Con A-CTL recover virtually all
of their initial cytolytic ability when treated with a-methyl-
mannoside, whereas after the same time at 370C removal of
surface Con A results in the recovery of only about half the
cytotoxic activity (measured in lytic units). In parallel with
this loss of function at 37°C, there was a decrease of about
50% (compared to control Con A-CTL at0°C) in the fluores-
cence intensity due to cell-associated RITC-Con A (Fig.
1B). There was also a similar loss at 37°C of a Con A recep-
tor, revealed by decreased binding of the FITC-labeled anti-
Ig that bound to anti-T200 antibody (Fig. 1C). Thus, Con A-
induced loss (modulation) of a cell surface glycoprotein was
associated with loss of cytotoxic activity. We define the in-
volved glycoproteins as Con A receptors because they are
evidently tightly bound by Con A on Con A-CTL.
Con A Receptors. To identify the Con A receptors, cloned
CTL (G4, B10, 1D, 2C, cr 15) were radiolabeled, incubated
with Con A, washed thoroughly, lysed with extraction buff-
er, and the labeled Con A receptors were isolated as com-
plexes with Con A by immunoprecipitation with anti-Con A
antibodies and Staph A. The receptors were then isolated
from the sedimented complexes by elution with a-methyl-
mannoside and visualized in autoradiographs of NaDodSO4/
polyacrylamide slab gels.
As shown in Fig. 2, only eight or nine labeled components
were generally seen, whereas in controls prepared by adding
Con A and anti-Con A antibodies to lysates of radiolabeled
CTL, many more labeled components (total Con A recep-
tors) were evident, in agreement with Henkart and Fisher
(21) (compare lanes A and B). Usually, a-methylmannoside
released 50-65% of the radiolabeled material from the Staph
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FIG. 1. Correlation between the loss of cytotoxic activity and the loss of Con A-binding receptors from the surface of CTL due to Con A-
induced modulation. (A) Effect of temperature on recovery of CTL activity after treatment of Con A-CTL with a-methylmannoside. CTL,
clone G4; target cells, P815. Curve 1, control (no pretreatment of CTL with Con A). Curve 2, CTL were pretreated with Con A (2.5 jug/ml, 1 hr
at 370C) and washed thoroughly to remove unbound Con A. The resulting cells (Con A-CTL) were then maintained for 4 hr at 370C, washed
with medium (no a-methylmannoside), and assayed. (The same results were obtained when the cells were kept 4 hr at 0C.) Curve 3, Con A-
CTL were kept at 0C for 4 hr, then washed with a-methylmannoside and assayed. Curve 4, Con A-CTL were kept at 370C for 4 hr, then
washed with a-methylmannoside and assayed. (B) Loss of cell-associated RITC-Con A from Con A-CTL (clone G4) during 4 hr incubation at
37TC. (I) Fluorescence of cell-bound RITC-Con A after incubating Con A-CTL (clone G4) for 4 hr at 0C. (II) Fluorescence of cell-bound
RITC-Con A after incubating Con A-CTL for 4 hr at 370C. (C) Lpss of a Con A-binding receptor (T200) from RITC-Con A-CTL during 4 hr
incubation at 370C. After 4-hr incubation with RITC-Con A at 0C (I) or 370C (IH), cells were treated with a-methylmannoside to remove cell-
bound RITC-Con A and then incubated with monoclonal anti-T200 rat antibody and FITC-labeled goat antibodies to rat 1g. (I) Fluorescence of
FITC-labeled reagent reveals T200 on the surface of RITC-Con A-CTL that were kept for 4 hr at 0C. (IH) Fluorescence of FITC-labeled
reagent reveals T200 on the surface of RITC-,:Con A-CTL that were kept for 4 hr at 370C. In control experiments, there were no significant
losses of H-2b after Con A-induced modulation on Con A-CTL.
A pellets; the residual material, extracted almost completely
by heating the pelleted Staph A in NaDodSO4/PAGE sample
buffer in a boiling water bath, contained the same compo-
nents that were seen in the a-methylmannoside extracts
(compare lane B with lane C). The most prominent compo-
nents (bands 1 and 2) were barely resolved in 7.5% gels and
not at all on 10% gels (compare lanes B and L). Bands 3, 4,
and 5 were of moderate intensity. The other bands were seen
only after prolonged exposure of the gels (lanes J and K).
Some of the components released by a-methylmannoside
from the Con A-anti-Con A antibody complexes were identi-
fied with monoclonal antibodies. As shown in Fig. 2 (lanes H
and I), mAb to T200 precipitated band 1 (Mr, 190,000), and
mAb to LFA-1 precipitated bands 2 and 5 (corresponding to
the a- and 1-chains of LFA-1 (6). On some of CTL clones
(e.g., clone G4) mAb to Lyt-2 precipitated band 8. The band
with Mr 25,000 (band C, lane K) represents radiolabeled Con
A. Band 9 is an unidentified protein with Mr similar to that of
Thy-1, but it is not precipitated by mAb to Thy-1.
To estimate the extent to which the various-receptors are
actually associated with Con A on the surface of intact Con
A-CTL, the cell lysates were subjected to sequential precip-
itations, first with antibodies to Con A and then with mAb to
the appropriate cell-surface antigens. The results indicated
that virtually all T200, about one-half of LFA-1, and less
than one-half of the Lyt-2 molecules on intact Con A-CTL
form stable complexes with Con A (added to the cells at 2.5
LLg of Con A per ml). Generally, the same pattern of Con A-
binding receptors seen with I251-labeled CTL was observed
with cells that were labeled metabolically-i.e., with
[355]methionine, mixtures of 3H-labeled amino acids and
[3H]mannose (data not shown).
Is it possible that some of the components that are immu-
noprecipitated from Con A-CTL by anti-Con A antibodies
are not themselves Con A-binding glycoproteins but rather
are associated tightly with such glycoproteins (i.e., with the
"real" Con A receptors)? To answer this question the 1251_
labeled materials from bands 1-9 were eluted from gels, and
their ability to bind to Con A-Sepharose 4B beads was test-
ed. Over 80% of 1251 from bands 1, 2, 3, 4, 5, and 9 and 50%o
of labeled material from bands 6 and 7 were strongly bound
to Con A-Sepharose.
DISCUSSION
In this study we have emphasized some properties ofCon A-
CTL, which are CTL that are prepared by incubating the
cells with Con A at low concentrations (1-5 ,ug/ml) and then
washing them extensively to leave on the cell surface only
Con A that is tightly bound to what are tentatively designat-
ed as "high affinity Con A-receptors." In comparison with
untreated CTL, these modified cells are greatly altered in
their functions: their cytotoxic activity is dramatically de-
creased (Fig. 1A; see ref. 8), and they produce y-IFN in the
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FIG. 2. Immunoprecipitation and NaDodSO4/PAGE of Con A
receptors from 125I-labeled CTL (clone G4). All lanes were from
1o gels except lane L (7.5% gel). Lane A, total cell-surface Con A-
binding glycoproteins revealed by the following: Ficoll-purified 125I-
labeled CTL were solubilized in Nonidet P-40, incubated with Con
A at 2.5 gg/ml and immunoprecipitated with anti-Con A antibody
and protein A-bearing Staph A. Lane B, high-affinity Con A-recep-
tors revealed by the following: Ficoll-purified 251I-labeled CTL were
treated with Con A at 2.5 g/mIl and washed to removed unbound
Con A; the resulting cells (Con A-CTL) were solubilized in Nonidet
P40 and immunoprecipitated with anti-Con A antibody and protein
A-Staph A. Con A-binding glycoproteins were extracted from the
immune complexes with a-methylmannoside and analyzed. Lane C,
same as lane B but analysis of the immunoprecipitated material that
remained on the Staph A pellets after a-methylmannoside extrac-
tion. Lane D, control in which 125I-labeled Con A-CTL were incu-
bated with 100 mM a-methylmannoside to remove Con A. Con A-
receptors were then isolated as described in lane B. Lane E, same as
lane D but analysis of the immunoprecipitated material that re-
mained on the Staph A pellets after a-methylmannoside extraction.
Lane F, control in which CTL were incubated with Con A (2.5
ttg/ml) in the presence of a-methylmannoside (50 mM) and subse-
quently proceeded as in lane B. Lane G, same as lane F but analysis
of the immunoprecipitated material that remained on the Staph A
pellets after a-methylmannoside extraction. Lane H, Con A-recep-
tors isolated as described in lane B were immunoprecipitated with
anti-T200 mAb. Lane I, Con A-receptors isolated as described in
lane B were immunoprecipitated with anti-LFA-1 mAb. Lane J,
overexposed lane B. Note bands 6, 7, 8, and 9. Lane K, overex-
posed lane C. "C" points to the 125I-labeled Con A that remained on
the pellets. Lane L, Con A-receptors isolated as described in lane B
were run on a 7.5% gel.
absence of antigen (Table 1). These pronounced changes are
all evidently due to the tightly bound Con A, as they are
reversed by eluting Con A from the CTL surface by a-meth-
ylmannoside. Because CTL normally appear to secrete
IFN only in response to specific interactions with their tar-
get cells (19), all of these observations suggest that the Con
A receptors include surface molecules that are intimately in-
volved in antigen recognition and effector functions of CTL.
Because of the relative stability of the complexes formed
by Con A with the receptors we were able to develop a pro-
cedure, based on the use of anti-Con A antibodies, to isolate
these receptors. The receptors were visualized as only 8 or 9
components on NaDodSO4/PAGE and some of them could
be accounted for by immunoprecipitation with mAb that are
known to block CTL activity (5, 6). Thus mAb to LFA-1
precipitated bands 2 and 5, which correspond to LFA-1 a-
(band 2) and B- (band 5) chains and anti-Lyt-2 antibody pre-
cipitated band 8 (on some clones).
A fourth component, the most intense band (band 1), was
completely immunoprecipitated by mAb to T200. Although
antibodies to T200 do not block CTL activity, studies report-
ed elsewhere (11) suggest that T200 may play a role in the
cytotoxic activity of CTL. In these studies tosyllysyl chloro-
methyl ketone, a well known serine protease inhibitor, has
been shown to block CTL activity probably by virtue of its
Table 1. Binding of Con A by receptors on cloned CTL induces
secretion of y-IFN
y-interferon in culture
Experimental conditions supernatant, units/ml*
CTLt <6
CTL and Con A (2 ug/ml) 12,288
Con A-CTL 12,888
Con A-CTL and a-methylmannosidet <6
*One unit of y-IFN is defined in ref. 19.
tClone 2C cells were incubated in 80% RPMI 1640/20% conditioned
medium (2 x 106 cells per ml). The conditioned medium was the
culture supernatant of the AOFS (20) cells grown 48 hr in the pres-
ence of Con A (5 ug/ml). The supernatant contained T-cell growth
factor (IL-2) but no y-IFN (19). Residual Con A was removed from
the conditioned medium by adsorption on Sephadex G-50. The
CTL were incubated 20 hr and t-IFN was assayed as described
(19).
tCon A-CTL were treated with a-methylmannoside as described
(8).
affinity-labeling of T200. It is of interest in this connection
that mAb to T200 do block the cytotoxic activity of natural
killer cells (22) and that cloned CTL under some culture con-
ditions can exhibit killing properties of natural killer cells
(23).
The unidentified Con A receptors of Mr 160,000 (band 3),
125,000 (band 4), 46,000 (band 6), and 23,000 (band 9), have
not previously been described. Whether they are involved in
CTL function is not known. One or more of these unidenti-
fied components may be involved in the induction of t-IFN
production, because antibodies to T200, LFA-1, and Lyt-2
separately and in combination fail to induce 'y-IFN produc-
tion by CTL.
There are several possible artifacts that could lead to un-
der- or overestimating the number of Con A receptors. The
possibility that glycoproteins from fetal calf serum are ad-
sorbed by CTL and misconstrued to be Con A receptors was
ruled out because all of the Con A receptors identified with
125I-labeled CTL could also be identified as a result of a met-
abolic labeling of the cells with [35S]methionine, 3H-labeled
amino acids. The possibility that some of the occupied Con
A receptors were lost by endocytosis or shed during prein-
cubation with Con A seems unlikely for two reasons. First,
the pretreatment period was too brief (30-45 min); second,
pretreatment with Con A at 0°C gave the same pattern of
Con A receptors as did the pretreatment at 370C.
To deal with the possibility that some of the Con A recep-
tors were dissociated from Con A during cell lysis with de-
tergent, we have used a photosensitive crosslinking reagent
coupled covalently to Con A. The results show that the same
set of cell-surface proteins (bands 1-9 in Fig. 2) were cross-
linked to Con A after light exposure was used to photoacti-
vate the crosslinking reagent on Con A (unpublished obser-
vations).
It seems clear, therefore, that the labeled components
shown in Fig. 1 represent the surface proteins on CTL that
form extremely stable complexes with Con A and that some
of them are involved in the effector function and activation
of CTL.
Identification of LFA-1 as one of the Con A receptors on
T-cell surface helps to explain some of the well known ef-
fects of Con A on lymphocytes. For example, Con A can
both induce IL-2 release from alloreactive cloned T cells and
inhibit proliferation of these cells (24). The paradoxical inhi-
bition of proliferation is probably due to interaction ofCon A
with LFA-1, because antibodies to LFA-1 are known to in-
hibit T-cell proliferation (25).
The approach described here provides opportunities to
isolate functionally interesting T-cell surface proteins with-
Proc. NatL Acad Sci. USA 81 (1984)
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out impairing their functional properties, because elution
with a-methylmannoside of immunoprecipitated material is
much milder than other methods of dissociating antigen from
antibodies in immunoprecipitates.
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